NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Covid-19 Data Analyses in Brazil

CompletedN/A

Sponsor: AstraZeneca

Conditions: Covid

Countries: Brazil

This descriptive study aims to describe the Brazilian scenario of patients hospitalized due to COVID-19 and to analyze the impact of COVID-19 on the Brazilian public health system. Data will be extracted from the largest secondary database of the Brazilian public health system, DATASUS ("Departamento de Informática do Sistema Único de Saúde"), responsible for collecting, processing, analyzing and disseminating health information and statistics in the country. The analysis, performed only on patients hospitalized during the hospitalization episode, will also evaluate the impact of vaccination against COVID-19 on the immunocompromised population compared to the general population.

Eligibility overview

Sex: ALL

Age: 18 Years to 80 Years

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* All individuals with COVID-19-related hospitalization. Individuals aged ≥18 years at the time of entry into the database.

Exclusion Criteria:

* Hospitalized patients with incomplete or missing data related to data linked in DATASUS.

Locations (1)

São Paulo, Brazil